Morgan Stanley’s IsoPlexis Corporation Common Stock ISO Stock Holding History

Morgan Stanley’s Portfolio ISO Stock Details ISO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-506,708	Closed	-$785K	–	7904
2022 Q4	$785K	Buy	506,708 +502,473	+11,865%	+$755K	﹤0.01%	5001
2022 Q3	$7K	Sell	4,235 -21,596	-84%	-$53.2K	﹤0.01%	7194
2022 Q2	$57K	Buy	25,831 +22,714	+729%	+$52.8K	﹤0.01%	6552
2022 Q1	$10K	Buy	3,117 +491	+19%	+$2.84K	﹤0.01%	7416
2021 Q4	$25K	Buy	+2,626	New	+$29.1K	﹤0.01%	7134

Morgan Stanley's ISO Position: Q1 2023 in Review

Morgan Stanley sold out of IsoPlexis Corporation Common Stock (ISO) in Q1 2023, closing a stake of 506,708 shares — an estimated $785K sold.

Morgan Stanley first reported a position in ISO in Q4 2021 and held it in 5 quarters. The position peaked at $785K in Q4 2022. 0 funds tracked by Wall St. Rank hold ISO as of Q1 2023.

Morgan Stanley reported no remaining IsoPlexis Corporation Common Stock position as of Q1 2023 after selling out during the quarter.
Morgan Stanley sold 506,708 IsoPlexis Corporation Common Stock shares in Q1 2023, an estimated $785K.
Morgan Stanley first reported a position in IsoPlexis Corporation Common Stock in Q4 2021 and held it in 5 quarters.
Morgan Stanley's IsoPlexis Corporation Common Stock position peaked at $785K in Q4 2022.
0 funds tracked by Wall St. Rank held IsoPlexis Corporation Common Stock as of Q1 2023.

Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.